![Christopher Leamon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Leamon
Director Técnico/Científico/I+D en FUSN PHAR .
Cargos activos de Christopher Leamon
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FUSN PHAR | Director Técnico/Científico/I+D | 02/11/2021 | - |
Historial de carrera de Christopher Leamon
Antiguos cargos conocidos de Christopher Leamon.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Advanced Accelerator Applications USA, Inc.
![]() Advanced Accelerator Applications USA, Inc. Medical SpecialtiesHealth Technology Part of Novartis AG, Advanced Accelerator Applications USA, Inc. develops, produces, and commercializes MNM diagnostic and therapeutic products. The company is based in New York, NY. | Corporate Officer/Principal | - | - |
Glaxo Wellcome Plc | Corporate Officer/Principal | - | - |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
ENDOCYTE, INC. | Director Técnico/Científico/I+D | 01/02/1999 | - |
Formación de Christopher Leamon.
Baldwin-Wallace College | Undergraduate Degree |
Purdue University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Reino Unido | 2 |
Canadá | 2 |
Operativa
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Glaxo Wellcome Plc | Health Technology |
Endocyte, Inc.
![]() Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Advanced Accelerator Applications USA, Inc.
![]() Advanced Accelerator Applications USA, Inc. Medical SpecialtiesHealth Technology Part of Novartis AG, Advanced Accelerator Applications USA, Inc. develops, produces, and commercializes MNM diagnostic and therapeutic products. The company is based in New York, NY. | Health Technology |
Fusion Pharmaceuticals, Inc.
![]() Fusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Leamon
- Experiencia